Polaris Group (United States)

Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis

Barbara Delage, Phuong Luong, L Maharaj et al. · Cell Death and Disease · 2012 · 153 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase

Marcus P. Kelly, Achim A. Jungbluth, B-W Wu et al. · British Journal of Cancer · 2011 · 123 citations · Full text

Medicine, Oncology, Pharmacology +17

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase

Lynn G. Feun, Angela Marini, Gail Walker et al. · British Journal of Cancer · 2012 · 113 citations · Full text

Medicine, Clinical Sciences, Oncology +15

A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas

Gregory R. Bean, Jeff C. Kremer, Bethany C. Prudner et al. · Cell Death and Disease · 2016 · 104 citations · Full text

Medicine, Oncology, Pharmacology +16

Predicting patient scores between the functional independence measure and the minimum data set: Development and performance of a fim-mds “crosswalk”

Brent C. Williams, Yi Li, Brant E. Fries et al. · Archives of Physical Medicine and Rehabilitation · 1997 · 88 citations

Nursing, Educational Measurement, Functional Assessment +16